Serum miRNA-1 may serve as a promising noninvasive biomarker for predicting treatment response in breast cancer patients receiving neoadjuvant chemotherapy.

Autor: Peng, Jing1 (AUTHOR), Lin, Yanping1 (AUTHOR), Sheng, Xiaonan1 (AUTHOR), Yuan, Chenwei1 (AUTHOR), Wang, Yan1 (AUTHOR), Yin, Wenjin1 (AUTHOR), Zhou, Liheng1 (AUTHOR) zhouliheng@renji.com, Lu, Jinsong1 (AUTHOR) lujjss@163.com
Zdroj: BMC Cancer. 7/2/2024, Vol. 24 Issue 1, p1-12. 12p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje